KR20050037107A - Cosmetic composition against aging of the skin - Google Patents
Cosmetic composition against aging of the skin Download PDFInfo
- Publication number
- KR20050037107A KR20050037107A KR1020030072542A KR20030072542A KR20050037107A KR 20050037107 A KR20050037107 A KR 20050037107A KR 1020030072542 A KR1020030072542 A KR 1020030072542A KR 20030072542 A KR20030072542 A KR 20030072542A KR 20050037107 A KR20050037107 A KR 20050037107A
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- cosmetic composition
- skin wrinkles
- improving skin
- breeding
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 61
- 239000002537 cosmetic Substances 0.000 title claims abstract description 40
- 230000032683 aging Effects 0.000 title description 3
- 239000000284 extract Substances 0.000 claims abstract description 128
- 230000037303 wrinkles Effects 0.000 claims abstract description 66
- 108010035532 Collagen Proteins 0.000 claims abstract description 26
- 102000008186 Collagen Human genes 0.000 claims abstract description 26
- 229920001436 collagen Polymers 0.000 claims abstract description 26
- 206010039491 Sarcoma Diseases 0.000 claims abstract description 22
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 14
- 238000003786 synthesis reaction Methods 0.000 claims abstract description 14
- 239000004480 active ingredient Substances 0.000 claims abstract description 9
- 238000009395 breeding Methods 0.000 claims description 36
- 230000001488 breeding effect Effects 0.000 claims description 36
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 21
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 17
- 239000000686 essence Substances 0.000 claims description 13
- 238000009472 formulation Methods 0.000 claims description 13
- 235000020712 soy bean extract Nutrition 0.000 claims description 12
- 239000002904 solvent Substances 0.000 claims description 10
- 125000004432 carbon atom Chemical group C* 0.000 claims description 7
- 239000002674 ointment Substances 0.000 claims description 7
- -1 pack Substances 0.000 claims description 6
- 238000000605 extraction Methods 0.000 claims description 5
- 238000004108 freeze drying Methods 0.000 claims description 5
- 239000006071 cream Substances 0.000 claims description 4
- 238000001694 spray drying Methods 0.000 claims description 4
- 238000004821 distillation Methods 0.000 claims description 3
- 239000006210 lotion Substances 0.000 claims description 3
- 239000003921 oil Substances 0.000 claims description 3
- 150000001298 alcohols Chemical class 0.000 claims description 2
- 239000002585 base Substances 0.000 claims description 2
- 239000006260 foam Substances 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 239000000344 soap Substances 0.000 claims description 2
- 239000008234 soft water Substances 0.000 claims description 2
- 230000000475 sunscreen effect Effects 0.000 claims description 2
- 239000000516 sunscreening agent Substances 0.000 claims description 2
- 238000000034 method Methods 0.000 claims 3
- 239000013040 bath agent Substances 0.000 claims 1
- 239000004816 latex Substances 0.000 claims 1
- 229920000126 latex Polymers 0.000 claims 1
- 230000001737 promoting effect Effects 0.000 abstract description 20
- 230000000694 effects Effects 0.000 abstract description 16
- 231100000957 no side effect Toxicity 0.000 abstract description 2
- 241001632576 Hyacinthus Species 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 65
- 230000000052 comparative effect Effects 0.000 description 24
- 230000036570 collagen biosynthesis Effects 0.000 description 15
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 10
- 210000002950 fibroblast Anatomy 0.000 description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 7
- 230000036571 hydration Effects 0.000 description 7
- 238000006703 hydration reaction Methods 0.000 description 7
- 239000008213 purified water Substances 0.000 description 7
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- 244000184734 Pyrus japonica Species 0.000 description 6
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 4
- 229930003268 Vitamin C Natural products 0.000 description 4
- 239000008278 cosmetic cream Substances 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- 239000000049 pigment Substances 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 235000019154 vitamin C Nutrition 0.000 description 4
- 239000011718 vitamin C Substances 0.000 description 4
- 229940058015 1,3-butylene glycol Drugs 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- 235000019437 butane-1,3-diol Nutrition 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000037394 skin elasticity Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 108090000672 Annexin A5 Proteins 0.000 description 2
- 238000011891 EIA kit Methods 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical class CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- QQONPFPTGQHPMA-UHFFFAOYSA-N Propene Chemical group CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 230000037319 collagen production Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 230000004215 skin function Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 1
- QGJZLNKBHJESQX-UHFFFAOYSA-N 3-Epi-Betulin-Saeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(=C)C)C5C4CCC3C21C QGJZLNKBHJESQX-UHFFFAOYSA-N 0.000 description 1
- VOUAQYXWVJDEQY-QENPJCQMSA-N 33017-11-7 Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)CCC1 VOUAQYXWVJDEQY-QENPJCQMSA-N 0.000 description 1
- CLOUCVRNYSHRCF-UHFFFAOYSA-N 3beta-Hydroxy-20(29)-Lupen-3,27-oic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C(O)=O)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C CLOUCVRNYSHRCF-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- DIZWSDNSTNAYHK-XGWVBXMLSA-N Betulinic acid Natural products CC(=C)[C@@H]1C[C@H]([C@H]2CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(=O)O DIZWSDNSTNAYHK-XGWVBXMLSA-N 0.000 description 1
- 108010075254 C-Peptide Proteins 0.000 description 1
- 241000195649 Chlorella <Chlorellales> Species 0.000 description 1
- 241000076824 Cistanche ambigua Species 0.000 description 1
- 241000336291 Cistanche deserticola Species 0.000 description 1
- 241000336315 Cistanche salsa Species 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 206010021639 Incontinence Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000308150 Orobanchaceae Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 206010051246 Photodermatosis Diseases 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 108010050808 Procollagen Proteins 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- QGJZLNKBHJESQX-FZFNOLFKSA-N betulinic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C QGJZLNKBHJESQX-FZFNOLFKSA-N 0.000 description 1
- 230000001851 biosynthetic effect Effects 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 239000003990 capacitor Substances 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- PZXJOHSZQAEJFE-UHFFFAOYSA-N dihydrobetulinic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(C)C)C5C4CCC3C21C PZXJOHSZQAEJFE-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 239000004459 forage Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- 238000010191 image analysis Methods 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 241000238565 lobster Species 0.000 description 1
- 210000000260 male genitalia Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- MQYXUWHLBZFQQO-UHFFFAOYSA-N nepehinol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C MQYXUWHLBZFQQO-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000008845 photoaging Effects 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 210000004706 scrotum Anatomy 0.000 description 1
- 210000001626 skin fibroblast Anatomy 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 210000000515 tooth Anatomy 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 230000037373 wrinkle formation Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/02—Preparations containing skin colorants, e.g. pigments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/70—Biological properties of the composition as a whole
- A61K2800/72—Hypo-allergenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/84—Products or compounds obtained by lyophilisation, freeze-drying
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Biotechnology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Cosmetics (AREA)
Abstract
본 발명은 피부 주름 개선용 화장료 조성물에 관한 것으로, 육종용(肉從蓉) 추출물 및 자초화(紫梢花) 추출물로 이루어진 군에서 선택되는 1종 이상의 추출물을 유효성분으로 포함하는 피부 주름 개선용 화장료 조성물에 관한 것이다. The present invention relates to a cosmetic composition for improving skin wrinkles, wherein the cosmetic composition for improving skin wrinkles comprising at least one extract selected from the group consisting of sarcoma extract and hyacinth extract as an active ingredient It relates to a composition.
본 발명의 피부 주름 개선용 화장료 조성물은 강력한 콜라겐 합성 촉진 효과가 있어서 피부에 도포하였을 때 주름 개선 효과가 매우 우수하며, 부작용도 발생하지 않아 안전성이 뛰어나다. The cosmetic composition for improving skin wrinkles of the present invention has a strong collagen synthesis promoting effect, and when applied to the skin, the wrinkle improving effect is very excellent, and no side effects occur.
Description
[산업상 이용분야] [Industrial use]
본 발명은 피부 주름 개선용 화장료 조성물에 관한 것으로서, 더욱 상세하게는 피부의 섬유아세포의 콜라겐합성을 촉진하여 피부의 탄력을 향상시키고, 피부 주름을 개선하는 효과가 우수한 피부 주름 개선용 화장료 조성물에 관한 것이다. The present invention relates to a cosmetic composition for improving skin wrinkles, and more particularly, to a skin composition for improving skin wrinkles by promoting collagen synthesis of fibroblasts of the skin to improve skin elasticity and improving skin wrinkles. will be.
[종래기술] [Private Technology]
세포외 기질(matrix)의 주요 구성 성분인 콜라겐은 피부의 섬유아세포에서 생성되는 주요 기질 단백질로서 세포 외 간질에 존재한다. 또한, 생체 단백질 총 중량의 약 30%를 차지하는 중요한 단백질로서 견고한 3중 나선구조를가지고 있다. 콜라겐은 피부, 건(tendon), 뼈 및 치아의 유기 물질의 대부분을 형성하는데, 특히 뼈와 피부 (진피)에 그 포함량이 높다. 대부분의 다른 체 구조물에서는 섬유상 봉입체로서 존재한다. Collagen, a major component of the extracellular matrix, is present in extracellular epilepsy as a major substrate protein produced in skin fibroblasts. It is also an important protein, accounting for about 30% of the total weight of biological proteins, and has a solid triple helix structure. Collagen forms most of the organic material of the skin, tendons, bones and teeth, especially in bones and skin (dermis). Most other sieve structures exist as fibrous inclusions.
콜라겐은 비교적 약한 면역원인데, 콜라겐의 나선 구조에 의한 잠재성 항원 결정인자의 차폐가 그 일부 원인이고, 이 나선 구조는 또한 콜라겐이 단백질 분해에 대한 내성을 갖도록 한다. 콜라겐의 주된 기능으로는 피부의 기계적 견고성, 결합조직의 저항력과 조직의 결합력, 세포 접착의 지탱, 세포 분할과 분화(유기체의 성장 혹은 상처 치유시)의 유도 등이 알려져 있다(Van der Rest 등, 1990). 이러한 콜라겐은 연령 및 자외선 조사에 의한 광노화에 의해 감소하며, 이는 피부의 주름 형성과 밀접한 연관이 있다고 알려져 있다(Arthur K. Balin et al., "Aging and the skin", 1989). 또한 근래에 들어 피부 노화에 대한 광범위한 연구가 발전되면서 피부에서의 콜라겐의 중요한 기능이 밝혀지고 있다. Collagen is a relatively weak immunogen, partly due to the shielding of latent antigenic determinants by the helix structure of collagen, which also makes collagen resistant to proteolysis. The main functions of collagen are known as mechanical firmness of skin, resistance of connective tissue and binding of tissue, support of cell adhesion, induction of cell division and differentiation (in organic growth or wound healing) (Van der Rest et al. 1990). This collagen is reduced by age and photoaging by UV irradiation, which is known to be closely associated with wrinkle formation of the skin (Arthur K. Balin et al., "Aging and the skin", 1989). In recent years, extensive research on aging of the skin has been developed to reveal the important function of collagen in the skin.
종래에는 콜라겐의 피부 보습 효과를 이용하기 위하여 화장품 등에 콜라겐을 배합한 제품들이 출시되어 있으나, 이들 화장품 등은 콜라겐을 피부 표면에 도포하는 것으로서 고분자 물질인 콜라겐의 경피 흡수가 어려워 보습작용을 기대할 수 없으므로 본질적인 피부 기능 개선이라고 말할 수 없었다. Conventionally, products using collagen have been released in order to take advantage of collagen's skin moisturizing effect.However, these cosmetics apply collagen to the surface of the skin. It could not be said to be an essential skin function improvement.
이러한 문제를 해결하기 위하여 콜라겐 합성 촉진 물질에 대한 관심이 높아졌으며, 종래에 알려진 콜라겐 합성 촉진 물질로는 비타민C 및 이의 유도체, 레티노익산(retinoic acid), 발암증식인자(TGF : transforming growth factor)(Cardinale G. et al, Adv. Enzymol., 41, p. 425, 1974), 동물 태반 유래의 단백질(JP8-231370), 베툴린산(betulinic acid)(JP8-208424), 클로렐라 추출물(JP9-40523, JP10-36283, 섬유아세포 증식 촉진작용) 등이 있다. In order to solve this problem, interest in collagen synthesis promoting material has been increased, and conventionally known collagen synthesis promoting materials include vitamin C and its derivatives, retinoic acid, and carcinogenic growth factor (TGF). Cardinale G. et al, Adv. Enzymol., 41, p. 425, 1974), protein from animal placenta (JP8-231370), betulinic acid (JP8-208424), chlorella extract (JP9-40523, JP10-36283, fibroblast proliferation promoting effect).
그러나, 이들 물질은 피부적용시 자극과 발적 등의 안전성의 문제로 사용량의 제한이 있거나 효과가 미미하여 실질적으로 피부 기능 개선 효과를 기대할 수 없다. 따라서, 기존의 피부 주름 개선 화장료 조성물보다 생체에 안전하고 효과가 높은 새로운 피부 주름 개선용 화장료 조성물의 개발이 절실히 요망되고 있다. However, these substances have limited use or insignificant effects due to safety problems such as irritation and redness during skin application, and thus, a substantial improvement in skin function cannot be expected. Therefore, there is an urgent need for the development of a new skin wrinkle improvement cosmetic composition that is safer and more effective in vivo than the existing skin wrinkle improvement cosmetic composition.
본 발명은 상기와 같은 종래의 문제점을 해결하기 위한 것으로서, 본 발명의 목적은 콜라겐의 합성을 촉진하여 피부의 탄력을 향상시키고, 피부 주름을 개선하는 효과가 우수한 피부 주름 개선용 화장료 조성물을 제공하는 것이다. The present invention is to solve the conventional problems as described above, an object of the present invention to promote the synthesis of collagen to improve the elasticity of the skin, to provide a cosmetic composition for improving skin wrinkles excellent skin wrinkles will be.
상기 목적을 달성하기 위하여, 본 발명은 육종용(肉從蓉) 추출물 및 자초화(紫梢花) 추출물로 이루어진 군에서 1종 이상 선택되는 추출물을 유효성분으로 포함하는 콜라겐 합성 촉진제 조성물을 제공한다. In order to achieve the above object, the present invention provides a collagen synthesis promoter composition comprising as an active ingredient an extract selected from the group consisting of sarcoma extract and jaehwa (紫 초 花) extract as an active ingredient.
본 발명은 또한, 육종용 추출물 및 자초화 추출물로 이루어진 군에서 선택되는 1종 이상의 추출물을 유효성분으로 포함하는 피부 주름 개선용 화장료 조성물을 제공한다. The present invention also provides a cosmetic composition for improving skin wrinkles comprising at least one extract selected from the group consisting of a breeding extract and a soybean extract as an active ingredient.
이하, 본 발명을 상세하게 설명한다. EMBODIMENT OF THE INVENTION Hereinafter, this invention is demonstrated in detail.
본 발명자들은 피부 주름 개선용 화장료 조성물의 유효성분으로서 우수한 콜라겐 합성 촉진 효과를 갖는 물질을 개발하던 중, 육종용 추출물과 자초화 추출물이 매우 강력한 콜라겐 합성촉진 효과가 있어 피부 주름 개선 효과가 매우 우수함을 밝혀 내고, 본 발명을 완성하게 되었다.The inventors of the present invention, while developing a substance having an excellent collagen synthesis promoting effect as an active ingredient of the cosmetic composition for improving skin wrinkles, it was found that the extracts for breeding and the soybean extract have a very strong collagen synthesis promoting effect, which is very excellent in improving skin wrinkles. The present invention was completed.
육종용(肉從蓉)은 열당과(Orobanchaceae)의 식물인 육종용(Cistanche salsa, Cistanche deserticola, Cistanche ambigua)의 육질 줄기로 맛은 달고 시고 짜며 독이 없다. 육종용는 남성의 음위, 여성의 불임증 대하 등의 치료에 사용된다.(중약대사전) 육종용의 성분연구에 의하면 다우코스테롤(daucosterol), 8-에피-로가닉산(8-epi-loganic acid), 헵타데카노일-베타-D-글루코피라노사이드(heptadecanoyl-beta-D-glucopyranoside) 등의 물질이 밝혀져 있다.(동양의약과학대전) 그러나 육종용 추출물의 콜라겐 생합성 촉진 및 주름개선에 관련된 특허는 지금까지 없었다. Breeding is a fleshy stem of the breeding plants of the Orobanchaceae, Cistanche salsa, Cistanche deserticola and Cistanche ambigua . Sarcoma is used for the treatment of male genitalia and infertility in women. Substances such as decanoyl-beta-D-glucopyranoside have been identified. .
자초화(紫梢花)는 강이나 호수에서 서식하는 담수해면과(Spongilladae)의 해면동물로써 대하, 소변의 백탁, 요실금, 음낭 습진을 치료한다.(중약대사전) 자초화의 성분연구에 의하면 스폰진(spongin), 스폰지닌(sponginin) 등이 보고된 바 있다. 그러나 자초화 추출물의 콜라겐 생합성 촉진 및 주름개선에 관련된 특허는 지금까지 없었다. Jahwahwa (紫 梢 花) is a sponge of the Spongilladae that lives in rivers or lakes. It treats lobster, urine whitening, incontinence, and scrotum eczema. Spongin, spongenin, and the like have been reported. However, there have been no patents related to promoting collagen biosynthesis and improving wrinkles of soybean extract.
본 발명의 콜라겐 생합성 촉진용 추출물은 육종용 및 자초화로 이루어진 군으로부터 1종 이상을 선택하여 각각 물, 탄소수 1 내지 4의 저급 알코올, 에틸아세테이트, 아세톤으로 1회 이상 추출하여 용매추출물을 얻을 수 있으며, 또한 상기 용매추출물인 추출액을 감압증류한 후, 동결건조 또는 분사건조하여 건조추출물을 얻을 수 있다. The collagen biosynthesis promoting extract of the present invention may be selected from one or more of the group consisting of breeding and self-priming to extract a solvent extract one or more times with water, lower alcohol having 1 to 4 carbon atoms, ethyl acetate, acetone, respectively, In addition, the solvent extract is distilled under reduced pressure, followed by freeze drying or spray drying to obtain a dry extract.
추출방법의 예를 들면, 생약재로 시판되는 육종용, 자초화 및 이들의 혼합물을 잘게 분쇄하고, 분쇄물 건조 중량에 대하여 5 내지 20 부피의 물이나, 탄소수 1 내지 4개의 무수 또는 함수 저급알코올, 에틸아세테이트 또는 아세톤으로 환류 냉각기가 달린 추출기에서 50 내지 100℃로 1 내지 5시간 가열하여 추출한다. 상기 추출액을 여과포로 여과한 후 잔사를 같은 방법으로 1회 이상 더 추출하여 여과하여 용매추출물을 얻는다. Examples of extraction methods, such as breeding, commercialization and mixtures thereof commercially available as a herbal medicine, finely pulverized, 5 to 20 volumes of water, anhydrous or hydrous lower alcohol, ethyl having 1 to 4 carbon atoms based on the dry weight of the ground powder Extraction is carried out with acetate or acetone by heating at 50-100 ° C. for 1-5 hours in an extractor equipped with a reflux condenser. The extract was filtered with a filter cloth, and the residue was extracted one more time in the same way and filtered to obtain a solvent extract.
또한 상기 여과된 용매추출물인 추출액을 합하여 감압농축한 후 동결건조또는 분무 건조하여 건조추출물을 얻는다. In addition, the filtered solvent extract extracts are combined and concentrated under reduced pressure, followed by freeze drying or spray drying to obtain a dry extract.
이러한 방법으로 제조된 육종용, 자초화 및 이들의 혼합 추출물은 인간유래의 섬유아세포에 대하여 매우 강력한 콜라겐 생합성 촉진 효과를 나타낸다. 또한 건조된 육종용 추출물 또는 자초화 추출물로 피부외용 연고나 화장료를 제조하여 사람의 피부에 도포하였을 때, 주름 개선 효과가 매우 우수하다. Breeding, self-cultivation and mixed extract thereof prepared in this way shows a very powerful collagen biosynthesis promoting effect on human-derived fibroblasts. In addition, when an external skin ointment or cosmetics are prepared as a dry sarcoma extract or a soybean extract, and applied to human skin, wrinkle improvement is very excellent.
상기 육종용, 자초화 및 이들의 혼합 추출물을 유효성분으로 포함하는 피부 주름 개선용 화장료 조성물을 제조하여 인체에 적용함으로써, 우수한 피부의 탄력과 피부주름개선 효과를 얻을 수 있다. By producing a cosmetic composition for improving skin wrinkles comprising the above breeding, self-priming and mixed extract thereof as an active ingredient and applied to the human body, it is possible to obtain an excellent skin elasticity and wrinkle improvement effect.
이 때 피부주름 개선용 화장료 조성물은 콜라겐 생성촉진제로서 육종용 및 자초화로 이루어진 군에서 선택되는 하나 이상의 추출물을 전체 중량에 대하여 건조 중량으로 0.0001 중량% 내지 10 중량% 포함할 수 있고, 바람직하게는 0.0005 중량% 내지 10 중량% 포함할 수 있으며, 더욱 바람직하게는 0.01 중량% 내지 10 중량% 포함할 수 있다. 0.0001중량%이하의 농도에서는 뚜렷한 효과를 기대할 수 없고, 10 중량%이상의 농도에서는 함유량의 증가에 따라 뚜렷한 효과의 증가가 나타나지 않는다. At this time, the cosmetic composition for improving skin wrinkles may include 0.0001% to 10% by weight of the dry weight with respect to the total weight of one or more extracts selected from the group consisting of breeding and self-inflation as a collagen production promoter, preferably 0.0005 weight % To 10% by weight may be included, and more preferably 0.01 to 10% by weight. At a concentration of less than 0.0001% by weight, no obvious effect can be expected, and at a concentration of 10% by weight or more, no apparent effect increases with the increase of the content.
또한, 본 발명에서 육종용 및 자초화 추출물을 혼합하여 사용하는 경우에 콜라겐 생성 촉진효과를 더욱 향상시킬 수 있다. 육종용 추출물과 자초화 추출물의 성분의 중량비는 3 : 1 내지 1 : 3이 바람직하다. In addition, in the present invention, when used in combination with the breeding and self-priming extract can further enhance the collagen production promoting effect. The weight ratio of the components of the breeding extract and the soybean extract is preferably 3: 1 to 1: 3.
본 발명에 따른 피부주름 개선용 화장료 조성물은 외용연고, 크림, 폼, 화장수, 팩, 유연수, 유액, 파운데이션, 메이크업베이스, 엣센스, 비누, 액체세정료, 입욕제, 선 스크린크림, 또는 선오일 등의 제형으로 제조할 수 있다. The cosmetic composition for improving skin wrinkles according to the present invention is an external ointment, cream, foam, lotion, pack, soft water, emulsion, foundation, makeup base, essence, soap, liquid cleanser, bathing agent, sunscreen cream, or sun oil It may be prepared in a dosage form.
또한 본 발명의 화장료 조성물은 일반 피부화장료에 배합되는 통상의 성분, 예를 들면 유분, 물, 계면활성제, 보습제, 저급알콜, 증점제, 킬레이트제, 색소, 방부제, 향료 등을 적절히 배합할 수 있다. In addition, the cosmetic composition of the present invention can be appropriately blended with conventional ingredients, such as oil, water, surfactants, moisturizers, lower alcohols, thickeners, chelating agents, pigments, preservatives, fragrances and the like, which are blended in general skin cosmetics.
이하 본 발명의 이해를 돕기 위하여 바람직한 실시예를 제시하나, 하기 실시예는 본 발명을 예시하는 것일 뿐 본 발명의 범위가 하기 실시예에 한정되는 것은 아니다. Hereinafter, preferred examples are provided to help understanding of the present invention, but the following examples are merely to illustrate the present invention, and the scope of the present invention is not limited to the following examples.
[실시예 1 내지 12] 육종용 또는 자초화의 추출물 추출 [Examples 1 to 12] Extract Extract of Breeding or Forage
시판되는 육종용 또는 자초화를 분쇄한 후, 상기 분쇄물 100 g을 물이나, 탄소수 1 내지 4개의 무수 또는 함수 저급알코올, 에틸아세테이트 또는 아세톤등의 용매 3 리터에 넣고, 냉각콘덴서가 달린 환류 추출기에서 3시간 끓여 추출한 다음, 100 메쉬 여과포로 여과한 후 잔사를 같은 방법으로 1회 더 추출하였다. 상기 각각의 단계에서 얻어진 추출액을 합하여 상온에서 화트만(Whatman) 2번 여과지로 여과하여 불용성 물질을 제거한 후, 냉각 콘덴서가 달린 증류장치에서 60℃로 감압농축한 후, 동결건조하여 건조 추출물을 얻었다. 각각의 경우에 사용한 생약재, 용매 및 얻어진 건조 추출물의 건조 중량을 하기 표1에 나타내었다.After crushing commercially available breeding or pyrophyllization, 100 g of the pulverized product is placed in 3 liters of water or a solvent having 1 to 4 carbon atoms, anhydrous or hydrous lower alcohol, ethyl acetate or acetone, and a reflux extractor equipped with a cooling capacitor. The mixture was boiled for 3 hours, extracted, filtered through a 100 mesh filter cloth, and the residue was extracted once more in the same manner. The extracts obtained in each of the above steps were combined and filtered using a filter filter of Whatman No. 2 at room temperature to remove insoluble materials, and then concentrated under reduced pressure at 60 ° C. in a distillation apparatus equipped with a cooling condenser, followed by freeze drying to obtain a dry extract. . The dry weights of the herbs, solvents and dry extracts obtained in each case are shown in Table 1 below.
[표 1]TABLE 1
[시험예 1] 실시예 1 내지 12의 추출물의 콜라겐 생합성 효과 Test Example 1 Collagen Biosynthesis Effect of Extracts of Examples 1 to 12
상기 실시예 1 내지 12에 따라 얻어진 각 추출물들을 인간유래의 섬유아세포의 배양액에 첨가하여 세포수준에서 콜라겐 합성촉진효과를 실험하였다. 생합성된 콜라겐의 측정은 PICP EIA kit(Procollagen Type I C-Peptide Enzyme ImmunoAssay KIT)를 이용하여 정량하였다. Each extract obtained according to Examples 1 to 12 was added to the culture solution of human-derived fibroblasts to test collagen synthesis promoting effect at the cellular level. Biosynthetic collagen was measured using a PICP EIA kit (Procollagen Type I C-Peptide Enzyme ImmunoAssay KIT).
실시예 1 내지 12에 따라 얻어진 각 추출물의 농도는 최종농도가 10 ㎍/ml이 되도록 하여 각각 인간유래의 섬유아세포의 배양배지에 첨가하여 1일간 배양한 후, 배양액을 취하여 PICP EIA Kit로 각 농도에서 콜라겐 생합성 정도를 분광광도계를 이용하여 450 nm에서 측정하였다. 콜라겐 생합성 효과를 비교하기 위하여 비타민 C(Vitamin C)를 첨가한 배양액과 추출물을 포함하지 않은 대조군에 대해서도 상기와 동일한 측정을 하였다. 콜라겐 생합성능은 대조군(무첨가)에 대한 상대적인 합성능으로 계산하고 결과를 표 2에 정리하였다. The concentration of each extract obtained according to Examples 1 to 12 was added to the culture medium of the fibroblasts derived from humans so that the final concentration was 10 ㎍ / ml, and cultured for 1 day, and then the culture solution was taken and each concentration was obtained by PICP EIA Kit. The degree of collagen biosynthesis at was measured at 450 nm using a spectrophotometer. In order to compare the collagen biosynthesis effect, the same measurement was performed for the culture medium and the control group without the extract containing vitamin C (Vitamin C). Collagen biosynthesis was calculated as the relative synthetic performance of the control (no addition) and the results are summarized in Table 2.
[표 2] 육종용 및 자초화 추출물의 세포수준에서의 콜라겐 생합성효과[Table 2] Collagen Biosynthesis Effect at the Cell Level of Sarcoma and Spontaneous Extracts
* 반복시험수 = 6 * Number of replicates = 6
상기 표 2의 결과에서 볼 수 있듯이 실시예 1 내지 12에 따라 얻어진 각 시료들은 전혀 정제되지 않은 추출물임에도 인간유래의 섬유아세포에 대하여 매우 우수한 콜라겐 생합성 촉진 효과가 있으며, 일반적으로 콜라겐 합성 능력이 있는 것으로 알려진 비타민 C를 적용한 경우보다 적은 농도로도 더 우수한 콜라겐 합성 효과를 얻을 수 있음을 알 수 있다. As can be seen from the results of Table 2, the samples obtained according to Examples 1 to 12 have very good collagen biosynthesis promoting effect on human-derived fibroblasts, even though the extracts were not purified at all, and generally have collagen synthesis ability. It can be seen that better collagen synthesis can be obtained at a lower concentration than the known vitamin C.
[시험예 2] [Test Example 2]
시험예 1과 같은 방법으로 인간유래의 섬유아세포에 대하여 상기 실시예 1 및 7의 추출물에 대하여 농도에 따른 콜라겐 생합성 촉진효과를 조사하였으며 그 결과를 표 3에 나타내었다. In the same manner as in Test Example 1, the collagen biosynthesis promoting effect according to the concentration of the extracts of Examples 1 and 7 was investigated with respect to the fibroblasts derived from humans, and the results are shown in Table 3.
[표 3] 추출물의 농도에 따른 세포수준에서의 콜라겐 생합성 촉진 효과 [Table 3] Collagen biosynthesis promoting effect at the cellular level according to the concentration of the extract
* 반복수 = 6 * Repetitions = 6
표 3의 결과에서 볼 수 있듯이 육종용 추출물 및 자초화 추출물은 인간유래의 섬유아세포에 대하여 매우 강력한 콜라겐 생합성 촉진효과를 가지고 있음을 알 수 있다. 또한 육종용 추출물 및 자초화 추출물의 함량이 증가할수록 콜라겐 생합성 촉진 효과가 증가하는 것을 알 수 있다. 따라서 육종용 추출물 및 자초화 추출물은 콜라겐 생합성 촉진용 추출물로 유용하게 사용될 수 있다. As can be seen from the results of Table 3, the sarcoma extract and the self-extracting extract have a very strong collagen biosynthesis promoting effect on human-derived fibroblasts. In addition, it can be seen that the collagen biosynthesis promoting effect increases as the content of the breeding extract and the soybean extract increases. Therefore, the sarcoma extract and the self-priming extract may be usefully used as an extract for promoting collagen biosynthesis.
[시험예 3] [Test Example 3]
6주령의 헤어리스 마우스를 이용하여 광에 의해 유발된 주름에 대하여 육종용 추출물 및 자초화 추출물의 주름개선 효과를 시험하였다. 실시예 3 및 9의 추출물을 1,3-부틸렌글리콜에 5 mg/ml로 녹여 적용하였으며 시험법은 다음과 같다. A 6-week-old hairless mouse was used to test the anti-wrinkle effect of the sarcoma extract and the apricot extract against light-induced wrinkles. The extracts of Examples 3 and 9 were dissolved in 5 mg / ml in 1,3-butylene glycol, and the test method was as follows.
헤어리스 마우스에 태양광 조사기(solar simulator)를 이용하여 2MED로 1주일에 3일 10주간 조사하여 주름을 형성시키고, 시료를 첨가하지 않은 1,3-부틸렌글리콜을 처리한 대조군과 5 mg/ml의 육종용, 자초화 추출물을 1일 2회 0.5 ml/cm2(실시예 3 및 9의 추출물로2.5 mg/cm2)씩 6주간 처리한 군을 대상으로 개선 정도를 정성 판단하였다.Hairless mice were irradiated with 2MED for 3 days and 10 days a week using a solar simulator to form wrinkles, and 5 mg / of a control treated with 1,3-butylene glycol without addition of the sample. The improvement degree was qualitatively determined for the group treated with 6 ml of breeding and self-priming extract of 0.5 ml / cm 2 (2.5 mg / cm 2 with the extracts of Examples 3 and 9) twice a day for 6 weeks.
주름개선 정도의 판단은 먼저 시료 처리 부위를 육안과 사진 촬영을 통해 육안판정하였고, 판정기준은 시료 처리군 및 대조군을 시료처리전과 비교하여 개선없음(1점), 약간의 개선(2점), 상당한 개선(3점)의 3단계로 판정하여 표 4에 나타내었다. Wrinkle improvement was judged by visual inspection and photographing of the sample treatment area first, and the criterion was no improvement (1 point), slight improvement (2 points), compared to the sample treatment group and the control group before the sample treatment. Table 3 shows the three stages of significant improvement (three points).
[표 4] 마우스에 대한 주름개선효과 [Table 4] Wrinkle improvement effect on the mouse
각 군의 개체수 = 10 Population in each group = 10
이상 살펴본 시험예 1 내지 3에 있어서 본 발명의 육종용 추출물 및 자초화 추출물에 의한 피부자극이나 부작용은 발견되지 않았다.In Test Examples 1 to 3 described above, no skin irritation or side effects were observed by the sarcoma extract and the soybean extract of the present invention.
이하 육종용 추출물 및 자초화 추출물을 포함하는 피부 주름 개선용 화장료 조성물의 제조 실시예 및 비교예를 나타낸다. Hereinafter, the preparation examples and comparative examples of the cosmetic composition for improving skin wrinkles, including the sarcoma extract and the jaehwa extract.
[실시예 13, 14 및 비교예 1] 피부 주름 개선용 피부 외용 연고 EXAMPLE 13, 14 AND COMPARATIVE EXAMPLE 1 Skin external ointment for skin wrinkle improvement
육종용 추출물을 포함하는 피부 주름 개선용 피부 외용연고의 제형과 자초화 추출물을 포함하는 피부 주름 개선용 피부 외용연고의 제형을 각각 실시예 13과 14로 제조하였으며, 상기 실시예 중 육종용 추출물 및 자초화 추출물을 포함하지 않는 것을 제외하고는 실시예 13 및 14와 동일하게 피부 외용연고를 제조한 것을 비교예 1로 하였다. 상세한 조성은 하기 표 5에 나타내었다. Formulations of external skin ointment for skin wrinkles including sarcoma extract and self-improvement Formulations of external skin ointment for skin wrinkles including extract for extract were prepared in Examples 13 and 14, respectively. Except not including the extract, Comparative Example 1 to prepare a skin external ointment in the same manner as in Examples 13 and 14. Detailed compositions are shown in Table 5 below.
[표 5] TABLE 5
[실시예 15, 16 및 비교예 2] 피부 주름 개선용 화장료 크림 [Examples 15, 16 and Comparative Example 2] Cosmetic Cream for Skin Wrinkle Improvement
육종용 추출물을 포함하는 피부 주름 개선용 화장료 크림의 제형과 자초화 추출물을 포함하는 피부 주름 개선용 화장료 크림의 제형을 각각 실시예 15와 16으로 제조하였으며, 상기 실시예 중 육종용 추출물 및 자초화 추출물을 포함하지 않는 것을 제외하고는 실시예 15 및 16과 동일하게 화장료 크림을 제조한 것을 비교예 2로 하였다. 상세한 조성은 하기 표 6에 나타내었다. Formulations of the cosmetic cream for skin wrinkle improvement comprising the extract for breeding and formulations of the cosmetic cream for skin wrinkle improvement including the soybean extract were prepared in Examples 15 and 16, respectively, the extract of sarcoma and extract of A cosmetic cream was prepared in the same manner as in Examples 15 and 16 except that it was not included as Comparative Example 2. Detailed compositions are shown in Table 6 below.
[표 6] TABLE 6
[실시예 17, 18 및 비교예 3] 피부 주름 개선용 유연화장수 [Examples 17, 18 and Comparative Example 3] supple cosmetics for improving skin wrinkles
육종용 추출물을 포함하는 피부 주름 개선용 유연화장수의 제형과 자초화 추출물을 포함하는 피부 주름 개선용 유연화장수의 제형을 각각 실시예 17과 18으로 제조하였으며, 상기 실시예 중 육종용 추출물 및 자초화 추출물을 포함하지 않는 것을 제외하고는 실시예 17 및 18과 동일하게 유연화장수를 제조한 것을 비교예 3으로 하였다. 상세한 조성은 하기 표 7에 나타내었다. Formulations of the skin for improving wrinkle wrinkles including sarcoma extract and formulation of skin softening for the improvement of skin wrinkles comprising a soybean extract were prepared in Examples 17 and 18, respectively, the extracts of sarcoma and extract of Except not including the same as in Example 17 and 18 to prepare a flexible longevity was set to Comparative Example 3. The detailed composition is shown in Table 7 below.
[표 7] TABLE 7
[실시예 19, 20 및 비교예 4] 피부 주름 개선용 영양화장수 [Examples 19, 20 and Comparative Example 4] Nourishing lotion for improving skin wrinkles
육종용 추출물을 포함하는 피부 주름 개선용 영양화장수의 제형과 자초화 추출물을 포함하는 피부 주름 개선용 영양화장수의 제형을 각각 실시예 19과 20으로 제조하였으며, 상기 실시예 중 육종용 추출물 및 자초화 추출물을 포함하지 않는 것을 제외하고는 실시예 19 및 20과 동일하게 영양화장수를 제조한 것을 비교예 4로 하였다. 상세한 조성은 하기 표 8에 나타내었다. Formulations of skin wrinkle improvement nutrient for longevity including sarcoma extract and formulation of skin wrinkle improvement nutrient for longevity including soybean extract were prepared in Examples 19 and 20, respectively. Comparative Example 4 was prepared in the same manner as in Examples 19 and 20 except that it does not contain. The detailed composition is shown in Table 8 below.
[표 8] TABLE 8
[실시예 21, 22 및 비교예 5] 피부 주름 개선용 화장료 팩 [Examples 21, 22 and Comparative Example 5] Cosmetic Pack for Skin Wrinkle Improvement
육종용 추출물을 포함하는 피부 주름 개선용 화장료 팩의 제형과 자초화 추출물을 포함하는 피부 주름 개선용 화장료 팩의 제형을 각각 실시예 21과 22로 제조하였으며, 상기 실시예 중 육종용 추출물 및 자초화 추출물을 포함하지 않는 것을 제외하고는 실시예 21 및 22와 동일하게 화장료 팩을 제조한 것을 비교예 5로 하였다. 상세한 조성은 하기 표 9에 나타내었다. Formulations of the skin wrinkle improvement cosmetic pack comprising a sarcoma extract and formulations of the skin wrinkle improvement cosmetic pack comprising a soybean extract were prepared in Examples 21 and 22, respectively, wherein the sarcoma extract and A cosmetic pack was prepared in the same manner as in Examples 21 and 22 except that it was not included as Comparative Example 5. Detailed compositions are shown in Table 9 below.
[표 9] TABLE 9
[실시예 23, 24 및 비교예 6] 피부 주름 개선용 화장료 엣센스 [Examples 23, 24 and Comparative Example 6] Cosmetic Essence for Skin Wrinkle Improvement
육종용 추출물을 포함하는 피부 주름 개선용 화장료 엣센스의 제형과 자초화 추출물을 포함하는 피부 주름 개선용 화장료 엣센스의 제형을 각각 실시예 23과 24로 제조하였으며, 상기 실시예 중 육종용 추출물 및 자초화 추출물을 포함하지 않는 것을 제외하고는 실시예 23 및 24와 동일하게 화장료 엣센스를 제조한 것을 비교예 6으로 하였다. 상세한 조성은 하기 표 10에 나타내었다. Formulations of the skin wrinkle improvement cosmetic essence comprising the sarcoma extract and formulations of the skin wrinkle improvement cosmetic essence comprising the saponification extract were prepared in Examples 23 and 24, respectively, in the above examples A cosmetic essence was prepared in the same manner as in Examples 23 and 24 except that it was not included as Comparative Example 6. The detailed composition is shown in Table 10 below.
[표 10] TABLE 10
[시험예 5] 본 발명의 피부 주름 개선용 화장료 엣센스의 주름개선효과 시험 [Test Example 5] Wrinkle improvement effect test of the cosmetic essence for skin wrinkle improvement of the present invention
상기 실시예 23, 24와 비교예 6의 엣센스에 대해서 건강한 35세에서 50세의 여성을 대상으로 피부 주름개선 효과를 다음과 같이 시험하였다. The skin wrinkle improvement effects of the essences of Examples 23 and 24 and Comparative Example 6 were tested in healthy 35 to 50 year old women as follows.
35세에서 50세까지의 여성 30명을 10명씩 3개의 군으로 구분하고 1군은 육종용 추출물을 5 중량% 포함하는 실시예 23의 엣센스를, 2군은 자초화 추출물을 5 중량% 포함하는 실시예 24의 엣센스를, 3군은 비교예 6의 엣센스를 안면부에 1일 1회 3개월간 도포하였다. Thirty women aged 35 to 50 years old were divided into three groups of 10 persons, and the first group contained the essence of Example 23 including 5% by weight of the sarcoma extract, and the second group contained 5% by weight of the acupuncture extract. The essence of Example 24 was applied to group 3, and the essence of comparative example 6 was applied to the face part once a day for 3 months.
3개월 후 피부 주름의 개선정도를 피험자의 설문 및 피부 주름의 영상분석을 통해 평가하였다. 피험자의 설문은 피부 주름개선 및 탄력증진에 관하여 사용전과 비교하여 개선없음(1점), 약간의 개선(2점), 상당한 개선(3점)의 3단계로 판정하였으며 결과는 표 11에 나타내었다. After 3 months, the improvement of skin wrinkles was evaluated by subject's questionnaire and image analysis of skin wrinkles. The subject's questionnaire was judged in three stages of improvement (1 point), slight improvement (2 points), and significant improvement (3 points) in comparison with the pre-use regarding skin wrinkle improvement and elasticity improvement. The results are shown in Table 11. .
[표 11] 본 발명의 피부 주름 개선용 화장료 엣센스의 피부 주름개선 효과(명) [Table 11] Skin wrinkle improvement effect of the cosmetic essence for skin wrinkle improvement of the present invention (person)
상기 표 11에서 볼 수 있듯이 본 발명에 의한 실시예 23 및 24의 엣센스를 사용한 경우 피부 주름 개선 효과가 우수함을 알 수 있다. As can be seen in Table 11, when using the essence of Examples 23 and 24 according to the present invention it can be seen that the skin wrinkle improvement effect is excellent.
이상 살펴본 바와 같이, 육종용 및 자초화로 이루어진 군에서 선택되는 1종 이상의 추출물은 인간 유래의 섬유아세포에 대하여 매우 강력한 콜라겐 생합성 촉진 효과가 있고, 부작용도 없어서, 이들 추출물을 함유한 화장료 조성물은 피부 주름 개선 효과가 매우 우수한 것을 알 수 있다.As described above, one or more extracts selected from the group consisting of sarcoma and self-inflamation have a very strong collagen biosynthesis promoting effect on fibroblasts derived from humans, and have no side effects, and thus the cosmetic composition containing these extracts improves skin wrinkles. It can be seen that the effect is very excellent.
본 발명의 피부 주름 개선용 화장료 조성물은 피부의 섬유아세포의 콜라겐 합성 촉진 효과가 있는 육종용 및 자초화로 이루어진 군에서 선택되는 1종 이상의 추출물을 포함하여 피부의 탄력을 향상시키고, 피부 주름을 개선하는 효과가 매우 우수하다. The cosmetic composition for improving skin wrinkles of the present invention includes at least one extract selected from the group consisting of sarcoma and soybean, which has an effect of promoting collagen synthesis of fibroblasts of the skin, thereby improving skin elasticity and improving skin wrinkles. Is very excellent.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020030072542A KR20050037107A (en) | 2003-10-17 | 2003-10-17 | Cosmetic composition against aging of the skin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020030072542A KR20050037107A (en) | 2003-10-17 | 2003-10-17 | Cosmetic composition against aging of the skin |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20050037107A true KR20050037107A (en) | 2005-04-21 |
Family
ID=37239990
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020030072542A KR20050037107A (en) | 2003-10-17 | 2003-10-17 | Cosmetic composition against aging of the skin |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20050037107A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008046258A1 (en) * | 2006-10-17 | 2008-04-24 | Hailong Wang | Cosmetic composition and preparation method and use thereof |
KR20150145903A (en) * | 2014-06-19 | 2015-12-31 | 주식회사 코스메카코리아 | A cosmetic composition for improving the refreshing and elasticity of skin comprising medicinal herbs |
-
2003
- 2003-10-17 KR KR1020030072542A patent/KR20050037107A/en not_active Application Discontinuation
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008046258A1 (en) * | 2006-10-17 | 2008-04-24 | Hailong Wang | Cosmetic composition and preparation method and use thereof |
KR20150145903A (en) * | 2014-06-19 | 2015-12-31 | 주식회사 코스메카코리아 | A cosmetic composition for improving the refreshing and elasticity of skin comprising medicinal herbs |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101796694B1 (en) | Cosmetic composition for improving skin whitening and lifting | |
JP4563521B2 (en) | Collagen production promoter and topical skin preparation | |
CN105362151A (en) | Cosmetic composition comprising coumestrol or a bean extract containing coumestrol for skin care | |
KR100435855B1 (en) | Composition for external application to the skin containing Opuntia ficus-indica extract | |
KR101352363B1 (en) | Composition of skin external application for moisturizing comprising Scrophularia buergeriana Miq. extract | |
US20140356468A1 (en) | Composition containing paper mulberry extracts | |
US6193975B1 (en) | Use of potentilla erecta extract in the cosmetic and pharmaceutical field | |
KR101860109B1 (en) | Skin external composition containing floral ginsenoside | |
KR101418986B1 (en) | Composition for promoting collagen synthesis and cosmetics comprising the same | |
US20230270660A1 (en) | Silybum marianum (L.) Gaertn. oil for reinforcing the barrier function of the skin | |
JP2012206957A (en) | Collagen production promoter | |
JP5175744B2 (en) | Cosmetic composition containing Kaimatsuko extract as an active ingredient | |
KR101154772B1 (en) | Cosmetic composition containing the zizyphus jujuba fruit extract and walnut extract for moisturizing effect on the skin | |
KR101220903B1 (en) | Composition of skin external for improving of skin wrinkle | |
KR101418979B1 (en) | Composition for accelerating collagen formation and cosmetics using the same | |
JP4129475B2 (en) | Collagen synthesis promoter and skin external preparation composition containing the same | |
KR100769577B1 (en) | Cosmetic composition for improving skin wrinkles | |
KR20050037107A (en) | Cosmetic composition against aging of the skin | |
KR20140079571A (en) | Composition for External Application to the Skin Using an Extract of Pachyrhizus erosus | |
KR101145814B1 (en) | Composition for improving skin wrinkle | |
KR100769579B1 (en) | Cosmetic composition for improving skin wrinkles | |
KR101897570B1 (en) | Composition for anti-wrinkle comprising handroanthus impetiginosus extract and method for preparing the extract | |
KR100769578B1 (en) | Cosmetic composition for improving skin wrinkles | |
WO2009001979A1 (en) | Novel use of sargachromenol | |
KR102430512B1 (en) | Reelin/vegf-c production/activation promoter and skin external composition using the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20031017 |
|
PG1501 | Laying open of application | ||
A201 | Request for examination | ||
PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20080918 Comment text: Request for Examination of Application Patent event code: PA02011R01I Patent event date: 20031017 Comment text: Patent Application |
|
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20101117 Patent event code: PE09021S01D |
|
E601 | Decision to refuse application | ||
PE0601 | Decision on rejection of patent |
Patent event date: 20110201 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20101117 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |